325 related articles for article (PubMed ID: 10687309)
1. Serum marker KL-6/MUC1 for the diagnosis and management of interstitial pneumonitis.
Kohno N
J Med Invest; 1999 Aug; 46(3-4):151-8. PubMed ID: 10687309
[TBL] [Abstract][Full Text] [Related]
2. [Clinical usefulness of KL-6 as a serum marker of idiopathic interstitial pneumonia].
Kohno N
Nihon Kyobu Shikkan Gakkai Zasshi; 1996 Dec; 34 Suppl():186-9. PubMed ID: 9216213
[TBL] [Abstract][Full Text] [Related]
3. [Use of the the ED046 kit to analyze serum KL-6 in patients with pneumonitis].
Kitamura S; Hiwada K; Kobayashi J; Kohno N; Kawai T; Satou A; Kasukawa R; Kawakami Y; Andou M; Nakada G; Inoue H; Itou K; Matsushima T; Ogura T; Arakawa M; Yamakido M
Nihon Kyobu Shikkan Gakkai Zasshi; 1996 Jun; 34(6):639-45. PubMed ID: 8741528
[TBL] [Abstract][Full Text] [Related]
4. [Clinical significance of serum KL-6 and SP-D for the diagnosis and treatment of interstitial lung disease in patients with diffuse connective tissue disorders].
Ogawa N; Shimoyama K; Kawabata H; Masaki Y; Wano Y; Sugai S
Ryumachi; 2003 Feb; 43(1):19-28. PubMed ID: 12692986
[TBL] [Abstract][Full Text] [Related]
5. [The clinical study on KL-6 and SP-D in sera of patients with various pulmonary diseases].
Sugimoto H; Okada E; Hashimoto N; Suzuki S; Yoshida H; Totani Y; Ameshima S; Ishizaki T; Miyamori I
Rinsho Byori; 2000 Jun; 48(6):554-60. PubMed ID: 10897675
[TBL] [Abstract][Full Text] [Related]
6. KL-6 as a novel serum marker for interstitial pneumonia associated with collagen diseases.
Nakajima H; Harigai M; Hara M; Hakoda M; Tokuda H; Sakai F; Kamatani N; Kashiwazaki S
J Rheumatol; 2000 May; 27(5):1164-70. PubMed ID: 10813282
[TBL] [Abstract][Full Text] [Related]
7. [Hypersensitivity pneumonitis monitored with serum KL-6, a marker of interstitial pneumonia].
Kobayashi J; Tsukagoshi M; Hagiwara S; Kitamura S; Hirota N; Saito K
Nihon Kyobu Shikkan Gakkai Zasshi; 1996 Jul; 34(7):837-42. PubMed ID: 8810769
[TBL] [Abstract][Full Text] [Related]
8. Detection of interstitial pneumonitis in patients with rheumatoid arthritis by measuring circulating levels of KL-6, a human MUC1 mucin.
Oyama T; Kohno N; Yokoyama A; Hirasawa Y; Hiwada K; Oyama H; Okuda Y; Takasugi K
Lung; 1997; 175(6):379-85. PubMed ID: 9330247
[TBL] [Abstract][Full Text] [Related]
9. [KL-6 in patients with interstitial pneumonitis].
Hamada H; Sakatani M; Ueda E
Nihon Kyobu Shikkan Gakkai Zasshi; 1996 Jul; 34(7):771-7. PubMed ID: 8810758
[TBL] [Abstract][Full Text] [Related]
10. [Assessment of serum markers KL-6 and SP-D for interstitial pneumonia associated with connective tissue diseases].
Suematsu E; Miyamura T; Shimada H; Nakao R; Yamamoto M
Ryumachi; 2003 Feb; 43(1):11-8. PubMed ID: 12692985
[TBL] [Abstract][Full Text] [Related]
11. Serum levels of KL-6 as a useful marker for evaluating pulmonary fibrosis in patients with systemic sclerosis.
Yamane K; Ihn H; Kubo M; Yazawa N; Kikuchi K; Soma Y; Tamaki K
J Rheumatol; 2000 Apr; 27(4):930-4. PubMed ID: 10782818
[TBL] [Abstract][Full Text] [Related]
12. Increased levels of KL-6 and subsequent mortality in patients with interstitial lung diseases.
Satoh H; Kurishima K; Ishikawa H; Ohtsuka M
J Intern Med; 2006 Nov; 260(5):429-34. PubMed ID: 17040248
[TBL] [Abstract][Full Text] [Related]
13. Serum level of KL-6 as a marker of interstitial lung disease in patients with juvenile systemic sclerosis.
Veselý R; Vargová V; Ravelli A; Massa M; Oleksák E; D'Alterio R; Martini A; De Benedetti F
J Rheumatol; 2004 Apr; 31(4):795-800. PubMed ID: 15088311
[TBL] [Abstract][Full Text] [Related]
14. Comparative studies of circulating KL-6, type III procollagen N-terminal peptide and type IV collagen 7S in patients with interstitial pneumonitis and alveolar pneumonia.
Kohno N; Yokoyama A; Hirasawa Y; Kondo K; Fujino S; Abe M; Hiwada K
Respir Med; 1997 Oct; 91(9):558-61. PubMed ID: 9415357
[TBL] [Abstract][Full Text] [Related]
15. KL-6 is a potential marker for interstitial lung disease associated with juvenile dermatomyositis.
Kobayashi I; Ono S; Kawamura N; Okano M; Miyazawa K; Shibuya H; Kobayashi K
J Pediatr; 2001 Feb; 138(2):274-6. PubMed ID: 11174630
[TBL] [Abstract][Full Text] [Related]
16. KL-6, a human MUC1 mucin, promotes proliferation and survival of lung fibroblasts.
Ohshimo S; Yokoyama A; Hattori N; Ishikawa N; Hirasawa Y; Kohno N
Biochem Biophys Res Commun; 2005 Dec; 338(4):1845-52. PubMed ID: 16289035
[TBL] [Abstract][Full Text] [Related]
17. Prognostic value of circulating KL-6 in idiopathic pulmonary fibrosis.
Yokoyama A; Kondo K; Nakajima M; Matsushima T; Takahashi T; Nishimura M; Bando M; Sugiyama Y; Totani Y; Ishizaki T; Ichiyasu H; Suga M; Hamada H; Kohno N
Respirology; 2006 Mar; 11(2):164-8. PubMed ID: 16548901
[TBL] [Abstract][Full Text] [Related]
18. KL-6: a serum marker for interstitial pneumonia.
Kobayashi J; Kitamura S
Chest; 1995 Aug; 108(2):311-5. PubMed ID: 7634858
[TBL] [Abstract][Full Text] [Related]
19. [Significance of serum KL-6 in diagnosis of interstitial pneumonia complicated with collagen disease].
Harigai M
Nihon Naika Gakkai Zasshi; 2003 Oct; 92(10):1985-9. PubMed ID: 14621589
[No Abstract] [Full Text] [Related]
20. KL-6 as an indicator for lymphocytic interstitial pneumonia (LIP) in a human T-lymphotrophic virus type 1 (HTLV-1) carrier.
Ishikawa N; Awaya Y; Maeda H; Miyazaki M; Fujitaka K; Yamasaki M; Kondo K; Oguri T; Isobe T; Kohno N
Ann Hematol; 2002 Aug; 81(8):474-7. PubMed ID: 12224007
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
